Prostaglandin D2 stimulates vasoactive intestinal polypeptide release into rat hypophysial portal blood.
The effect of prostaglandin D2 (PGD2) on vasoactive intestinal polypeptide (VIP) release from the hypothalamus was examined by determining plasma VIP levels in rat hypophysial portal blood. Intraventricular injection of PGD2 (5 micrograms/rat) caused a 3-fold increase in the concentration of plasma VIP in hypophysial portal blood in anesthetized rats. A PGD2 metabolite, 13,14-dihydro-15-keto PGD2, did not affect VIP levels in portal blood. The flow rate of hypophysial portal blood was not changed after the injection of PGD2. The intraventricular injection of PGD2, but not PGD2 metabolite, resulted in an increase in peripheral plasma prolactin (PRL) levels in the rat. These findings suggest that PGD2 plays a stimulatory role in regulating VIP release from the hypothalamus into hypophysial portal blood and causes PRL secretion from the pituitary in rats.
D000818:Animals; D007700:Kinetics; D008297:Male; D010902:Pituitary Gland / Q000098:blood supply* / Q000187:drug effects / Q000378:metabolism*; D011388:Prolactin / Q000097:blood; D015230:Prostaglandin D2; D011457:Prostaglandins D / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains; D014660:Vasoactive Intestinal Peptide / Q000378:metabolism*
D011457:Prostaglandins D; D014660:Vasoactive Intestinal Peptide; D011388:Prolactin; D015230:Prostaglandin D2